Disease Resistance and Susceptibility
Interpret disease resistance, tolerance, and susceptibility as genotype-by-pathogen-by-environment traits; use replicated Cannabis evidence without converting one resistant accession, locus, or trial into a universal cultivar claim.
Interpret disease resistance, tolerance, and susceptibility as genotype-by-pathogen-by-environment traits; use replicated Cannabis evidence without converting one resistant accession, locus, or trial into a universal cultivar claim.
Core science
Cannabis genotypes vary substantially in disease susceptibility. Direct screening has documented large differences in powdery-mildew severity among Cannabis sativa germplasm, including entries with consistently low disease in replicated trials, and a 2026 Septoria study likewise found substantial susceptibility variation among accessions.
Resistance is pathogen specific. A genotype with low powdery-mildew severity should not be assumed resistant to Septoria, Botrytis, Fusarium, HLVd, BCTV, or another disease unless that interaction has been tested.
Genetic studies have identified Cannabis loci associated with powdery-mildew susceptibility or resistance, including evidence near CsMLO1. A candidate locus can strengthen biological understanding but does not make phenotype independent of genetic background, pathogen population, environment, or experimental design.
Resistance and tolerance are different. A plant can support pathogen infection yet show limited yield or quality loss, while another plant can suppress pathogen growth more effectively. Studies should therefore report both disease/pathogen measurements and host performance where possible.
Apparent field resistance can be confounded by escape: later development, canopy architecture, microclimate, vector exposure, inoculum distribution, or sampling time may reduce observed disease without a true physiological resistance mechanism. Replication across time, environments, and pathogen populations improves confidence.
Why this matters in cultivation
- Keep disease observations linked to exact genotype or accession identity rather than broad market labels such as indica, sativa, hemp, or hybrid.
- Compare genotypes under similar disease pressure and measurement methods before ranking susceptibility; uncontrolled exposure differences can create false resistance impressions.
- Record disease severity separately from growth, yield, flower quality, or other performance so resistance and tolerance are not conflated.
- Treat resistance as one layer of integrated disease management, not a replacement for pathogen-free propagation, scouting, biosecurity, environmental management, and diagnosis.
Measure and record
Genetic identity
Record cultivar/accession, source, propagation lot, and any verified pedigree or marker information relevant to the study.
Pathogen challenge
Record pathogen species/strain or population, inoculation/natural-exposure context, disease pressure, and confirmation method.
Disease phenotype
Use a defined incidence/severity scale, pathogen quantification where available, dates, plant stage, and assessor method.
Host performance
Record growth, survival, flowering, yield or quality metrics separately from pathogen measurements when evaluating tolerance.
Replication/context
Record number of plants/replicates, seasons/environments, experimental blocks, and environmental conditions so stability of the response can be evaluated.
Common misconceptions
Misconception: A cultivar resistant to one disease is broadly disease-resistant.
Misconception: No visible disease in one crop cycle proves genetic resistance.
Misconception: A resistance-associated marker guarantees the same phenotype in every genetic background.
Misconception: Tolerance and resistance mean the same thing.
Misconception: Genotype ranking from one environment is automatically stable across all production systems.
Evidence limits and uncertainty
Cannabis resistance research is rapidly expanding but remains uneven across diseases. Powdery mildew and Septoria now have direct replicated germplasm evidence, while many other pathosystems have smaller datasets. Public claims should specify pathogen, genotype, trial conditions, endpoint, and whether resistance was replicated.
Check your reasoning
- For "Disease Resistance and Susceptibility", explain the mechanism behind this objective: Interpret disease resistance, tolerance, and susceptibility as genotype-by-pathogen-by-environment traits; use replicated Cannabis evidence without converting one resistant accession, locus, or trial into a universal cultivar claim. Which observation or measurement would best test whether that mechanism is operating in the real crop?
- A learner claims, "A cultivar resistant to one disease is broadly disease-resistant." Use the lesson’s science and evidence limits to explain why that claim is unreliable, then name one observation or measurement that could separate the competing explanations.
- Applied case — Keep disease observations linked to exact genotype or accession identity rather than broad market labels such as indica, sativa, hemp, or hybrid. Build a verification plan using the lesson’s record set (Genetic identity, Pathogen challenge, Disease phenotype). What would you compare before and after the action, and what result would make you revise the original interpretation?
Require lesson-specific evidence, not memorized universal targets. Open the rationales after you have written or discussed your own answer.
Answer rationale 1: Mechanism / workflow rationale
- A strong answer should connect the response to the lesson objective: Interpret disease resistance, tolerance, and susceptibility as genotype-by-pathogen-by-environment traits; use replicated Cannabis evidence without converting one resistant accession, locus, or trial into a universal cultivar claim.
- Cannabis genotypes vary substantially in disease susceptibility. Direct screening has documented large differences in powdery-mildew severity among Cannabis sativa germplasm, including entries with consistently low disease in replicated trials, and a 2026 Septoria study likewise found substantial susceptibility variation among accessions.
- Resistance is pathogen specific. A genotype with low powdery-mildew severity should not be assumed resistant to Septoria, Botrytis, Fusarium, HLVd, BCTV, or another disease unless that interaction has been tested.
- The most useful verification evidence includes Genetic identity: Record cultivar/accession, source, propagation lot, and any verified pedigree or marker information relevant to the study.
- Keep this limit explicit: Cannabis resistance research is rapidly expanding but remains uneven across diseases. Powdery mildew and Septoria now have direct replicated germplasm evidence, while many other pathosystems have smaller datasets. Public claims should specify pathogen, genotype, trial conditions, endpoint, and whether resistance was replicated.
Answer rationale 2: Misconception rationale
- The shortcut is unreliable because the lesson explicitly teaches a more conditional explanation.
- Representative misconception: A cultivar resistant to one disease is broadly disease-resistant.
- Cannabis genotypes vary substantially in disease susceptibility. Direct screening has documented large differences in powdery-mildew severity among Cannabis sativa germplasm, including entries with consistently low disease in replicated trials, and a 2026 Septoria study likewise found substantial susceptibility variation among accessions.
- A useful discriminator is Pathogen challenge: Record pathogen species/strain or population, inoculation/natural-exposure context, disease pressure, and confirmation method.
- Do not overextend the conclusion beyond this limit: Cannabis resistance research is rapidly expanding but remains uneven across diseases. Powdery mildew and Septoria now have direct replicated germplasm evidence, while many other pathosystems have smaller datasets. Public claims should specify pathogen, genotype, trial conditions, endpoint, and whether resistance was replicated.
Answer rationale 3: Applied verification rationale
- In practice: Keep disease observations linked to exact genotype or accession identity rather than broad market labels such as indica, sativa, hemp, or hybrid.
- Record before action: Genetic identity: Record cultivar/accession, source, propagation lot, and any verified pedigree or marker information relevant to the study.
- Also record: Pathogen challenge: Record pathogen species/strain or population, inoculation/natural-exposure context, disease pressure, and confirmation method.
- After the action, repeat the same measurement or observation so the comparison is valid.
- Revise the interpretation if the result conflicts with the lesson limit or the expected response: Cannabis resistance research is rapidly expanding but remains uneven across diseases. Powdery mildew and Septoria now have direct replicated germplasm evidence, while many other pathosystems have smaller datasets. Public claims should specify pathogen, genotype, trial conditions, endpoint, and whether resistance was replicated.
Related lessons
Sources and evidence
- Screening Diverse Cannabis sativa Germplasm for Resistance to Golovinomyces ambrosiae. Plant Disease. 2026. PMID:41319034. doi:10.1094/PDIS-07-25-1591-RE. https://pubmed.ncbi.nlm.nih.gov/41319034/
- Schwartz JA, et al. Screening of Cannabis sativa Germplasm for Susceptibility to Septoria Leaf Spot. Plant Disease. 2026;110(5):1750-1756. PMID:40920100. doi:10.1094/PDIS-07-25-1367-RE. https://pubmed.ncbi.nlm.nih.gov/40920100/
- Genetic Mapping, Identification, and Characterization of a Candidate Susceptibility Gene for Powdery Mildew in Cannabis sativa. Plant Disease. 2024. PMID:37750850. https://pubmed.ncbi.nlm.nih.gov/37750850/
- Buirs L, Punja ZK. Integrated Management of Pathogens and Microbes in Cannabis sativa L. under Greenhouse Conditions. Plants. 2024;13(6):786. PMID:38592798. https://pmc.ncbi.nlm.nih.gov/articles/PMC10974757/
Downloads
No lesson-specific download is approved for this release. Use browser print/save-to-PDF when you need an offline reading copy.